TCL Archive NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines November 26, 1993
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005